AbaStar MDx Inc. develops blood-based gene expression, molecular diagnostic tests for the accurate diagnosis of mental disorders and neurodegenerative diseases. From a simple blood sample, the Company's gene expression products detect and measure the unique disease-specific gene profile or molecular signature. Determining the molecular signature of a disease from a sample of blood revolutionizes diagnostic technology. For brain disorders, this breakthrough technology enables accurate diagnosis with a laboratory test for the first time. The resultant early detection, patient monitoring, disease progression and effective treatment of these diseases will eliminate years of suffering through misdiagnoses and expensive trial and error medication treatments.